Sudarshan Sharma, MD
Gynecologic Oncology · Hinsdale, ILNPI 1740265974
Payments from drug & device makers
Across 271 payments — averaging $9554.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.5M
- GSK$665K
- Genentech, Inc.$202K
- AstraZeneca$149K
- Clovis Oncology, Inc.$103K
- Pharmaand GmbH$5K
- plus $1K from 15 others
Across 3 payments — averaging $1419.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Karyopharm Therapeutics Inc.$3K
- F. Hoffmann-la Roche AG$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 134 | $1,464,039 |
| GSK | 23 | $665,093 |
| Genentech, Inc. | 22 | $202,431 |
| AstraZeneca | 14 | $148,694 |
| Clovis Oncology, Inc. | 30 | $102,540 |
| Pharmaand GmbH | 4 | $5,130 |
| Eisai Inc. | 16 | $355 |
| Intuitive Surgical | 4 | $247 |
| Seagen Inc. | 9 | $177 |
| Genentech USA, Inc. | 2 | $128 |
| Baxter Healthcare | 1 | $65 |
| Pfizer | 2 | $43 |
| AbbVie | 2 | $32 |
| Celltrion USA Inc. | 1 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $19 |
| Immunogen, Inc. | 1 | $18 |
| Lumenis, Inc | 1 | $16 |
| Olympus America Inc. | 1 | $15 |
How this compares
$2,589,142 in reported general payments places this provider in the 95th percentile of 64 gynecologic oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Hinsdale
- John MoroneyChicago$3.3M
- Dario RoqueChicago$1.2M
- Amina AhmedChicago$1.1M
- Emma BarberChicago$897K
- Julian SchinkChicago$388K
- Jenna MarcusChicago$381K
- Nikki NeubauerOak Lawn$260K
- Summer DewdneyChicago$241K
- Emily HinchcliffChicago$142K
- Raanan AlterWarrenville$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.